MAP2K7 and malignant peripheral nerve sheath tumor: The drug synergism we have observed when combining MEK inhibitors with other drugs in addition to INK128 (Supplementary Table 3) lends further support to the burgeoning model that suggests exposing both plexiform neurofibromas and MPNST cells to MEK inhibition sensitizes them to other strategies that might not demonstrate noticeable activity alone.